{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:09:12Z","timestamp":1778476152351,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","award":["#T32 CA009120"],"award-info":[{"award-number":["#T32 CA009120"]}],"id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["DBG-23\\u20131152703-01-TBE"],"award-info":[{"award-number":["DBG-23\\u20131152703-01-TBE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA237401-01A1"],"award-info":[{"award-number":["R01CA237401-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002192","name":"LUNGevity Foundation","doi-asserted-by":"publisher","award":["857709"],"award-info":[{"award-number":["857709"]}],"id":[{"id":"10.13039\/100002192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023561","name":"Graduate Education at UCLA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016427","name":"Eugene McDermott Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.lungcan.2025.108581","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T19:24:24Z","timestamp":1746905064000},"page":"108581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel murine carcinogen-induced model recapitulates the progression and heterogeneity of human lung adenocarcinoma"],"prefix":"10.1016","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-9562","authenticated-orcid":false,"given":"Aparamita","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefany","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9392-7420","authenticated-orcid":false,"given":"Adriana","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn Alcaraz","family":"Jr.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreya","family":"Jaldu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Quezada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Dumitras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-1992","authenticated-orcid":false,"given":"Pasquale","family":"Saggese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8083-8062","authenticated-orcid":false,"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-5654","authenticated-orcid":false,"given":"Gregory A.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2379-5486","authenticated-orcid":false,"given":"John","family":"Belperio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Dubinett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1188-8124","authenticated-orcid":false,"given":"Claudio","family":"Scafoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"467","key":"10.1016\/j.lungcan.2025.108581_b0005","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat5933","article-title":"Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma","volume":"10","author":"Scafoglio","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lungcan.2025.108581_b0010","article-title":"Glucose deprivation promotes pseudo-hypoxia and de-differentiation in lung adenocarcinoma","author":"Saggese","year":"2023","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108581_b0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"24","key":"10.1016\/j.lungcan.2025.108581_b0020","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev."},{"issue":"7345","key":"10.1016\/j.lungcan.2025.108581_b0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature09881","article-title":"Suppression of lung adenocarcinoma progression by Nkx2-1","volume":"473","author":"Winslow","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.lungcan.2025.108581_b0030","first-page":"3164","article-title":"Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A\/J mouse","volume":"52","author":"Belinsky","year":"1992","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108581_b0035","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.ajpath.2016.03.020","article-title":"CD4(+)CD25(hi)Foxp3(+) Cells Exacerbate Bleomycin-Induced Pulmonary Fibrosis","volume":"186","author":"Birjandi","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108581_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1165\/rcmb.2005-0330OC","article-title":"Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility","volume":"36","author":"Razani-Boroujerdi","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108581_b0045","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1593\/neo.08406","article-title":"Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+\/- mice","volume":"10","author":"Hollander","year":"2008","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.lungcan.2025.108581_b0050","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1016\/j.sjbs.2021.08.001","article-title":"Lung cancer induced by Benzo(A)Pyrene: ChemoProtective effect of sinapic acid in swiss albino mice","volume":"28","author":"Hu","year":"2021","journal-title":"Saudi J Biol Sci"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108581_b0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/jcp.2003.007138","article-title":"Thyroid transcription factor 1 in pulmonary adenocarcinoma","volume":"57","author":"Stenhouse","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2025.108581_b0060","unstructured":"M. Mlika, F. Anjum, A. Sankari, F. El Mezni, Pulmonary Papilloma, StatPearls, Treasure Island (FL), 2025."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108581_b0065","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1093\/ejcts\/ezv316","article-title":"International association for the study of lung cancer\/american thoracic society\/european respiratory society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma","volume":"49","author":"Yeh","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108581_b0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108581_b0075","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200247","article-title":"Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories","volume":"11","author":"Hynds","year":"2021","journal-title":"Open Biol."},{"issue":"42","key":"10.1016\/j.lungcan.2025.108581_b0080","doi-asserted-by":"crossref","first-page":"E6409","DOI":"10.1073\/pnas.1613601113","article-title":"Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma","volume":"113","author":"McFadden","year":"2016","journal-title":"PNAS"},{"issue":"7535","key":"10.1016\/j.lungcan.2025.108581_b0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature13898","article-title":"The mutational landscapes of genetic and chemical models of Kras-driven lung cancer","volume":"517","author":"Westcott","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108581_b0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.11.024","article-title":"Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy","volume":"44","author":"Pfirschke","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.lungcan.2025.108581_b0095","doi-asserted-by":"crossref","unstructured":"P. Saggese, C.A. Martinez, L.M. Tran, R. Lim, C. Dumitras, T. Grogan, D. Elashoff, S.R. Ramin, S.M. Dubinett, B. Liu, C. Scafoglio, Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer, Cancers (Basel) 13(14) (2021).","DOI":"10.3390\/cancers13143595"},{"key":"10.1016\/j.lungcan.2025.108581_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823618","article-title":"Immunotherapy in Lung Cancer: Current Landscape and Future Directions","volume":"13","author":"Mamdani","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108581_b0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.6837","article-title":"Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis","volume":"7","author":"Banna","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.lungcan.2025.108581_b0110","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-020-02837-9","article-title":"Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden","author":"Salehi-Rad","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108581_b0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/jox14010006","article-title":"Relevance of Carcinogen-Induced Preclinical Cancer Models","volume":"14","author":"Sewduth","year":"2024","journal-title":"J Xenobiot"},{"issue":"9","key":"10.1016\/j.lungcan.2025.108581_b0120","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41416-018-0300-x","article-title":"Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK","volume":"119","author":"Watson","year":"2018","journal-title":"Br. J. Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225004738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225004738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:27:12Z","timestamp":1778473632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225004738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"alternative-id":["S0169500225004738"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108581","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel murine carcinogen-induced model recapitulates the progression and heterogeneity of human lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108581"}}